IPO Listed
Kardigan IPO
US$400m raised
Lodged 17 Jun 2026 · NASDAQ: KARD · US$16.00 cash per share
Advisers
Lead managers
- Bookrunner
- J.P. Morgan
(co)Jefferies
(co)Leerink Partners (co)TD Securities (co) - Legal adviser
- Issuer
- Kardigan
- Issuer based in
- United States
- Listed
- Jun 2026
- Sector
- Biotech
- Tags
- Biotech, Cardiovascular, Drug Development
In the league tables
Similar deals
- Braveheart Bio IPO Aug 2026 · US$383m · Biotech
- Generate Biomedicines IPO Feb 2026 · US$400m · Biotech
- Korsana Biosciences placement Apr 2026 · US$380m · Biotech
- Eikon Therapeutics IPO Feb 2026 · US$381m · Oncology
- ADARx Pharmaceuticals IPO Sep 2026 · US$446m · Biotech
Sources
- Jun 2026 Latham Advises on Kardigan IPO lw.com
- 18 Jun 2026 Final IPO prospectus (424B4), Kardigan, Inc. sec.gov
- 22 Jun 2026 Goodwin Advises Kardigan on Closing of $460 Million Upsized Initial Public Offering goodwinlaw.com

